Silver Book Fact

An experimental drug may help those women whose breast cancer worsens despite use of other therapies. The medicine was shown in studies to nearly double the time breast cancer was suppressed. It is also thought that it may cross the blood-brain barrier, suppressing the spread of breast cancer to the brain.

Pollack A. New Drug Holds Promise for Type of Breast Cancer. The New York Times. June 4 2006. http://www.nytimes.com/2006/06/04/health/04cancer.html?ex=1159329600&en=691f887bb3d95f4b&ei=5070

Reference

Title
New Drug Holds Promise for Type of Breast Cancer
Publication
The New York Times
Publication Date
June 4 2006
Authors
Pollack A
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Gains in healthy years of life and social value from cancer R&D
     
  • A drug that can reduce the risk of breast cancer in high-risk women costs approximately $1,050 per year. The average cost per year for surgery or other invasive methods of…  
  • Over the next 10 years, the number of cancer survivors in the U.S. is predicted to grow from 14.5 million to nearly 19 million (9.3 million men and 9.6 million…  
  • FDA Cancer Approvals for Aug 2014 to July 2015
     
  • FDA approved cancer advances